Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -85.42% is 65% above its 5-year average of -244.26%, near the high end of its 5-year range (-1243.63%–79.32%).
76.68% above its 12-month average of -366.29%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 30.57%.
EBITDA MARGIN
-85.42%
EBITDA MARGIN AVG TTM
-366.29%
EBITDA MARGIN AVG 3Y
-250.50%
EBITDA MARGIN AVG 5Y
-244.26%
EBITDA MARGIN AVG 10Y
-207.90%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+76.68%
CURRENT VS 3Y AVG
+65.90%
CURRENT VS 5Y AVG
+65.03%
CURRENT VS 10Y AVG
+58.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
REGENXBIO Inc.
Market Cap
$385.15M
EBITDA Margin
-85.42%
TTM Avg
-366.29%
3Y Avg
-250.50%
5Y Avg
-244.26%
Market Cap
$380.37M
EBITDA Margin
-2.13%
TTM Avg
-2.60%
3Y Avg
-2.91%
5Y Avg
0.10%
Market Cap
$376.01M
EBITDA Margin
-12.87%
TTM Avg
-20.20%
3Y Avg
-216.20%
5Y Avg
-209.97%
Market Cap
$374.50M
EBITDA Margin
-403.32%
TTM Avg
-429.38%
3Y Avg
-429.38%
5Y Avg
-429.38%
Market Cap
$396.31M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
Market Cap
$397.99M
EBITDA Margin
-59.97%
TTM Avg
-74.12%
3Y Avg
-94.06%
5Y Avg
-94.06%
Market Cap
$369.50M
EBITDA Margin
-107.01%
TTM Avg
-86.79%
3Y Avg
-53.66%
5Y Avg
-431.14%
Market Cap
$402.17M
EBITDA Margin
-8579.24%
TTM Avg
-8579.24%
3Y Avg
-8579.24%
5Y Avg
-8579.24%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| REGENXBIO Inc. (RGNX) | $385.15M | -85.42% | -366.29% | -250.50% | -244.26% |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | -2.13% | -2.60% | -2.91% | 0.10% |
| Zura Bio Limited (ZURA)vs › | $376.19M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $376.01M | -12.87% | -20.20% | -216.20% | -209.97% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | -403.32% | -429.38% | -429.38% | -429.38% |
| Shoulder Innovations, Inc. (SI)vs › | $396.31M | -48.80% | -44.09% | -45.35% | -45.35% |
| Carlsmed, Inc. (CARL)vs › | $397.99M | -59.97% | -74.12% | -94.06% | -94.06% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | -107.01% | -86.79% | -53.66% | -431.14% |
| Neurogene Inc. (NGNE)vs › | $402.17M | -8579.24% | -8579.24% | -8579.24% | -8579.24% |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | -1.71% | -2.46% | -6.59% | -11.17% |
Gross Margin
88.1%
EBITDA Margin
-85.4%
Operating Margin
-94.1%
Net Margin
-112.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 30.57% |
| 2026-03-31 | -1243.63% |
| 2025-12-31 | -177.23% |
| 2025-09-30 | -163.20% |
| 2025-06-30 | -277.98% |
| 2025-03-31 | 18.07% |
| 2024-12-31 | -223.18% |
| 2024-09-30 | -240.18% |
| 2024-06-30 | -233.17% |
| 2024-03-31 | -368.60% |
| 2023-12-31 | -268.17% |
| 2023-09-30 | -209.55% |
| 2023-06-30 | -343.76% |
| 2023-03-31 | -323.85% |
| 2022-12-31 | -171.14% |
| 2022-09-30 | -254.59% |
| 2022-06-30 | -183.44% |
| 2022-03-31 | -310.27% |
| 2021-12-31 | 79.32% |
| 2021-09-30 | -177.17% |
| 2021-06-30 | -227.03% |
| 2021-03-31 | -223.01% |
| 2020-12-31 | -240.36% |
| 2020-09-30 | 16.30% |
| 2020-06-30 | -239.65% |
| 2020-03-31 | -202.37% |
| 2019-12-31 | -326.32% |
| 2019-09-30 | -231.50% |
| 2019-06-30 | -445.67% |
| 2019-03-31 | -3879.19% |
| 2018-12-31 | 9.22% |
| 2018-09-30 | -410.55% |
| 2018-06-30 | 18.10% |
| 2018-03-31 | 77.69% |
| 2017-12-31 | -778.19% |
| 2017-09-30 | -1542.14% |
| 2017-06-30 | -218.73% |
| 2017-03-31 | -4916.04% |
| 2016-12-31 | -1190.39% |
| 2016-09-30 | -14806.40% |
| 2016-06-30 | -627.20% |
| 2016-03-31 | -2850.64% |
| 2015-12-31 | -123.04% |
| 2015-09-30 | -642.02% |
| 2015-06-30 | -460.82% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | -191.55% |
| 2014-09-30 | -347.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 27.95% |
